Abilene Boy Home After Battling Rare Covid-19 Syndrome

 

ABILENE, TX – After spending more than a week at Cook Children's Medical Center combating serious medical issues, 11-year-old Cason Abbott is finally home.

Cason faced major health problems after being diagnosed with Multisystem Inflammatory Syndrome in Children. 

According to the Center for Disease Control, MIS-C can cause inflammation of different body parts that include the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. 

The fifth-grader spent days in the ICU after his blood pressure dropped as low as 44/26 and he dealt with an inflamed and swollen heart.

According to Cason's mother, Angie Abbott, he is home but has a long road of recovery ahead.

"He's lost a lot of weight and he looks real frail, but he has his color back in his face and his face, hands, and feet aren’t swollen," said Abbott. "He will be on medication at home which includes daily shots."

According to Abbott, Cason won't be back to full speed for at least three months, but he is slowly acting more like himself.

"He even was cracking a couple of jokes earlier about what he could do to aggravate me," said Abbott. "I was like I know he's back to feeling good if he's wondering what he can do to aggravate me."

The first thing Cason wanted to do was drink a Dr. Pepper as soon as he left the hospital.

Cason will have to travel to Fort Worth every week to visit with his team of doctors for the time being.

Subscribe to the LIVE! Daily

The LIVE! Daily is the "newspaper to your email" for San Angelo. Each content-packed edition has weather, the popular Top of the Email opinion and rumor mill column, news around the state of Texas, news around west Texas, the latest news stories from San Angelo LIVE!, events, and the most recent obituaries. The bottom of the email contains the most recent rants and comments. The LIVE! daily is emailed 5 days per week. On Sundays, subscribers receive the West Texas Real Estate LIVE! email.

Required

Most Recent Videos

Post a comment to this article here:

X Close